ArticleTherapeutic advances in chronic disease2022

Predicting the individualized risk of nonadherence to zoledronic acid among osteoporosis patients receiving the first infusion of zoledronic acid: development and validation of new predictive nomograms.

Chong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.